HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Description of an AGPAT2 pathologic allelic variant in a 54-year-old Caucasian woman with Berardinelli-Seip syndrome.

Abstract
A 54-year-old Italian female patient was admitted to our Department with the diagnosis of type 2 diabetes poorly controlled with insulin therapy. The patient was born by consanguineous parents (first degree cousins); she had acromegaloid features, diffuse lipoatrophy and muscular pseudo-hypertrophy since childhood. To confirm the clinical hypothesis of congenital generalized lipodystrophy (CGL) or Berardinelli-Seip syndrome, the sequences of AGPAT2 (encoding for 1-acyl-sn-glycerol-3-phosphate acyltransferase beta) and BSCL2 (encoding for seipin) candidate genes were analyzed. DNA analysis showed the presence of a homozygous mutation in exon 3 of the AGPAT2 gene (P112L). This is the first description of a Caucasian subject with CGL who carries the pathologic allelic variant P112L of the AGPAT2 gene.
AuthorsCaterina Pelosini, Silvia Martinelli, Brunella Bagattini, Enrico Pucci, Paola Fierabracci, Giovanna Scartabelli, Guido Salvetti, Paolo Vitti, Margherita Maffei, Aldo Pinchera, Ferruccio Santini
JournalActa diabetologica (Acta Diabetol) Vol. 48 Issue 3 Pg. 243-6 (Sep 2011) ISSN: 1432-5233 [Electronic] Germany
PMID21744063 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Acyltransferases
  • 2-acylglycerophosphate acyltransferase
Topics
  • Acyltransferases (genetics)
  • Alleles
  • Base Sequence
  • Consanguinity
  • DNA Mutational Analysis
  • Female
  • Genetic Variation (physiology)
  • Humans
  • Lipodystrophy, Congenital Generalized (genetics)
  • Middle Aged
  • Models, Biological
  • Pedigree
  • White People (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: